436 related articles for article (PubMed ID: 19132231)
1. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
2. Location of the multimerin 1 binding site in coagulation factor V: an update.
Jeimy SB; Quinn-Allen MA; Fuller N; Kane WH; Hayward CP
Thromb Res; 2008; 123(2):352-4. PubMed ID: 18452976
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
[TBL] [Abstract][Full Text] [Related]
5. Differential contributions of Glu96, Asp102 and Asp111 to coagulation factor V/Va metal ion binding and subunit stability.
Song J; Talbot K; Hewitt J; MacGillivray RT; Pryzdial EL
Biochem J; 2009 Aug; 422(2):257-64. PubMed ID: 19522703
[TBL] [Abstract][Full Text] [Related]
6. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
Villoutreix BO; Dahlbäck B
Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
[TBL] [Abstract][Full Text] [Related]
7. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-stimulated human platelets express molecular forms of alpha-granule factor V (FV), which differ from FVa.
Wyshock EG; Stewart GJ; Colman RW
Thromb Haemost; 1994 Dec; 72(6):947-56. PubMed ID: 7740469
[TBL] [Abstract][Full Text] [Related]
9. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.
Majumder R; Weinreb G; Lentz BR
Biochemistry; 2005 Dec; 44(51):16998-7006. PubMed ID: 16363813
[TBL] [Abstract][Full Text] [Related]
10. Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3.
Adam F; Zheng S; Joshi N; Kelton DS; Sandhu A; Suehiro Y; Jeimy SB; Santos AV; Massé JM; Kelton JG; Cramer EM; Hayward CP
Thromb Haemost; 2005 Nov; 94(5):1004-11. PubMed ID: 16363244
[TBL] [Abstract][Full Text] [Related]
11. Identification of the MMRN1 binding region within the C2 domain of human factor V.
Jeimy SB; Woram RA; Fuller N; Quinn-Allen MA; Nicolaes GA; Dahlbäck B; Kane WH; Hayward CP
J Biol Chem; 2004 Dec; 279(49):51466-71. PubMed ID: 15452129
[TBL] [Abstract][Full Text] [Related]
12. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
13. Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.
Suzuki H; Shima M; Nogami K; Sakurai Y; Nishiya K; Saenko EL; Tanaka I; Yoshioka A
J Thromb Haemost; 2006 Jun; 4(6):1354-60. PubMed ID: 16706982
[TBL] [Abstract][Full Text] [Related]
14. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
Koklic T; Chattopadhyay R; Majumder R; Lentz BR
Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
[TBL] [Abstract][Full Text] [Related]
15. Human platelets contain forms of factor V in disulfide-linkage with multimerin.
Hayward CP; Fuller N; Zheng S; Adam F; Jeimy SB; Horsewood I; Quinn-Allen MA; Kane WH
Thromb Haemost; 2004 Dec; 92(6):1349-57. PubMed ID: 15583744
[TBL] [Abstract][Full Text] [Related]
16. Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line.
Isordia-Salas I; Manns JM; Sainz I; Parekh H; DeLa Cadena RA
Thromb Res; 2005; 116(6):533-43. PubMed ID: 16181989
[TBL] [Abstract][Full Text] [Related]
17. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
Solymoss S; Nguyen KT
Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
[TBL] [Abstract][Full Text] [Related]
18. Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.
Erdogan E; Bukys MA; Orfeo T; Mann KG; Kalafatis M
Thromb Haemost; 2007 Nov; 98(5):998-1006. PubMed ID: 18000604
[TBL] [Abstract][Full Text] [Related]
19. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
Dharmawardana KR; Bock PE
Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
